ABL Bio Inc (298380) — Capital Reinvestment Ratio
Latest as of March 2026:
0.01x
ABL Bio Inc (298380) has a Capital Reinvestment Ratio of 0.01x as of March 2026, meaning it reinvests 0% of its operating cash flow (₩32.84 Billion) in capital expenditures (₩243.74 Million). See 298380 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
₩32.84 Billion
KRW
Capital Expenditures
₩243.74 Million
KRW
Data as of
Mar 2026
Most recent filing
ABL Bio Inc Capital Reinvestment Ratio (2022–2022)
This chart tracks ABL Bio Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for ABL Bio Inc (2022–2022)
Year-by-year Capital Reinvestment Ratio for ABL Bio Inc from 2022 to 2022. For live market cap and broader valuation context, see ABL Bio Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.03x | ₩72.13 Billion | ₩2.06 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow